Ron Cohen - 12 Nov 2021 Form 4 Insider Report for ACORDA THERAPEUTICS INC

Role
President and CEO, Director
Signature
/s/ Ron Cohen
Issuer symbol
N/A
Transactions as of
12 Nov 2021
Net transactions value
$0
Form type
4
Filing time
15 Nov 2021, 15:34:01 UTC
Previous filing
08 Sep 2021
Next filing
21 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACOR Employee Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 12 Nov 2021 Common Stock 100,000 $3.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options issued under the Issuer's 2015 Omnibus Incentive Compensation Plan. The shares subject to these options vest in equal quarterly installments over four years beginning on November 12, 2021, with the first quarterly installment vesting on February 12, 2022.